Docetaxel in Non Small Cell Lung Cancer (NSCLC)

NCT00263016 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
50
Enrollment
INDUSTRY
Sponsor class

Stopped Slow recruitment

Conditions

Interventions

Sponsor

Sanofi